Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helicobacter pylori membrane proteins and phospholipids constitute the outer surface of the Gram-negative bacterium H. pylori, which is uniquely adapted to survive the harsh acidic environment of the human stomach. This target encompasses a variety of outer membrane proteins (OMPs), such as the Hop family (e.g., BabA and SabA), which are critical for bacterial adhesion to the gastric epithelium and subsequent colonization (UniProt, 2024). The phospholipid bilayer is also distinct, containing high levels of cholesterol glucosides that contribute to the bacterium's structural stability and resistance to host defenses (PubMed, 2022). Therapeutically, this surface complex is targeted by bismuth-containing compounds, which disrupt membrane integrity and inhibit essential bacterial enzymes, leading to cell death. Because H. pylori is a primary causative agent of chronic gastritis, peptic ulcers, and gastric cancer, these membrane components are vital for both pathogenesis and as sites for antimicrobial intervention. Furthermore, the specific protein and lipid signatures of the H. pylori membrane are being explored for the development of novel vaccines and targeted delivery systems for antibiotics (NIH, 2023).
Bismuth salts exert antimicrobial effects by binding to the bacterial cell wall and membrane, causing structural damage and lysis; they also inhibit bacterial enzymes such as urease and prevent the adherence of H. pylori to gastric epithelial cells (StatPearls, 2023). Experimental antimicrobial peptides target the specific phospholipid composition of the H. pylori membrane to induce pore formation and cytoplasmic leakage (PubMed, 2021).
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helicobacter pylori membrane proteins and phospholipids.